| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Inflamm Res] 2024 Jun; Vol. 73 (6), pp. 1019-1031. <i>Date of Electronic Publication: </i>2024 Apr 24.
- MeSH Terms: Angiotensin I* / therapeutic use ; Angiotensin I* / pharmacology ; Angiotensin I* / administration & dosage ; Peptide Fragments* / pharmacology ; Peptide Fragments* / therapeutic use ; Peptide Fragments* / administration & dosage ; Lung* / drug effects ; Lung* / pathology ; Lung* / immunology ; Lipopolysaccharides* ; Ovalbumin* / immunology ; Animals ; Mice ; Male ; Macrophages / drug effects ; Macrophages / immunology ; Eosinophils / drug effects ; Eosinophils / immunology ; Mice, Inbred BALB C ; Inflammation / drug therapy ; Eosinophilia / drug therapy ; Eosinophilia / immunology ; Bronchoalveolar Lavage Fluid / immunology ; Bronchoalveolar Lavage Fluid / cytology
- References: Felton JM, Lucas CD, Rossi AG, Dransfield I. Eosinophils in the lung—modulating apoptosis and efferocytosis in airway inflammation. Front Immunol. 2014;1:5. ; Feehan KT, Gilroy DW. Is resolution the end of inflammation? Trends Mol Med. 2019;25(3):198–214. (PMID: 3079597210.1016/j.molmed.2019.01.006) ; Levy BD, Vachier I, Serhan CN. Resolution of inflammation in asthma. Clin Chest Med. 2012;33(3):559–70. (PMID: 22929102343159910.1016/j.ccm.2012.06.006) ; Motwani MP, Newson J, Kwong S, Richard-Loendt A, Colas R, Dalli J, et al. Prolonged immune alteration following resolution of acute inflammation in humans. PLoS ONE. 2017;12(10):1. (PMID: 10.1371/journal.pone.0186964) ; Newson J, Motwani MP, Kendall AC, Nicolaou A, Muccioli GG, Alhouayek M, et al. Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1/mPGES-1-derived prostaglandin E2. Cell Rep. 2017;20(13):3162–75. (PMID: 28954232563914610.1016/j.celrep.2017.08.098) ; Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med. 2005;172(7):824–30. (PMID: 15961693271840310.1164/rccm.200410-1413OC) ; Fernandez-Boyanapalli R, Goleva E, Kolakowski C, Min E, Day B, Donald YML, et al. Obesity impairs apoptotic cell clearance in asthma. J Allergy Clin Immunol. 2013;131(4):1041–7. (PMID: 2315408210.1016/j.jaci.2012.09.028) ; Duncan CJA, Lawrie A, Blaylock MG, Douglas JG, Walsh GM. Reduced eosinophil apoptosis in induced sputum correlates with asthma severity. Eur Respir J. 2003;22(3):484–90. (PMID: 1451613910.1183/09031936.03.00109803a) ; Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2014;16(1):45–56. (PMID: 10.1038/ni.3049) ; Hekking PPW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. (PMID: 2544163710.1016/j.jaci.2014.08.042) ; Lachowicz-Scroggins ME, Boushey HA, Finkbeiner WE, Widdicombe JH. Interleukin-13—induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection. Am J Respir Cell Mol Biol. 2010;43(6):652–61. (PMID: 20081054299308610.1165/rcmb.2009-0244OC) ; Davis MF, Peng RD, McCormack MC, Matsui EC. Staphylococcus aureus colonization is associated with wheeze and asthma among US children and young adults. J Allergy Clin Immunol. 2015;135(3):811–3. (PMID: 2553352610.1016/j.jaci.2014.10.052) ; Wan H, Winton HL, Soeller C, Tovey ER, Gruenert DC, Thompson PJ, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Investig. 1999;104(1):123–33. (PMID: 1039370640840110.1172/JCI5844) ; Sousa LP, Pinho V, Teixeira MM. Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19? Br J Pharmacol. 2020;177(17):3898–904. (PMID: 32557557732315610.1111/bph.15164) ; Gregório JF, da Rodrigues-Machado MG, Santos RAS, Carvalho-Ribeiro IA, Nunes OM, Oliveira IFA, et al. Asthma: role of the angiotensin-(1–7)/Mas (MAS1) pathway in pathophysiology and therapy. Br J Pharmacol. 2021;178(22):4428–39. (PMID: 3423572510.1111/bph.15619) ; Magalhães GS, Barroso LC, Reis AC, Rodrigues-Machado MG, Gregório JF, Motta-Santos D, et al. Angiotensin-(1–7) promotes resolution of eosinophilic inflammation in an experimental model of asthma. Front Immunol. 2018;9:1. (PMID: 10.3389/fimmu.2018.00058) ; Magalhães GS, Gregório JF, Cançado Ribeiro ATP, Baroni IF, de Vasconcellos AVO, Nakashima GP, et al. Oral formulation of angiotensin-(1–7) promotes therapeutic actions in a model of eosinophilic and neutrophilic asthma. Front Pharmacol. 2021;12:557962. (PMID: 33762930798257710.3389/fphar.2021.557962) ; Magalhães GS, Gregório JF, Ramos KM, Tonani A, Baroni IF, Barcelos LS, et al. Treatment with inhaled formulation of angiotensin-(1–7) reverses inflammation and pulmonary remodeling in a model of chronic asthma. Immunobiology. 2020;225(3):151957–67. (PMID: 3251788010.1016/j.imbio.2020.151957) ; Magalhães GS, Rodrigues-Machado MG, Motta-Santos D, Alenina N, Bader M, Santos RA, et al. Chronic allergic pulmonary inflammation is aggravated in angiotensin-(1–7) Mas receptor knockout mice. Am J Physiol Lung Cell Mol Physiol. 2016;2016:1. ; Magalhães GS, Rodrigues-Machado MG, Motta-Santos D, Silva AR, Caliari MV, Prata LO, et al. Angiotensin-(1–7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation. Br J Pharmacol. 2015;2015:1. ; Rodrigues-Machado MG, Magalhães GS, Cardoso JA, Kangussu LM, Murari A, Caliari MV, Oliveira ML, Cara DC, Noviello ML, Marques FD, Pereira JM, Lautner RQ, Santos RA, Campagnole-Santos MJ. AVE 0991, a non-peptide mimic of angiotensin-(1–7) effects, attenuates pulmonary remodelling in a model of chronic asthma. Br J Pharmacol. 2013;170(4):835–46. (PMID: 23889691379959710.1111/bph.12318) ; El-Hashim AZ, Renno WM, Raghupathy R, Abduo HT, Akhtar S, Benter IF. Angiotensin-(1–7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways. Br J Pharmacol. 2012;166(6):1964–76. (PMID: 22339213340281810.1111/j.1476-5381.2012.01905.x) ; El-Hashim AZ, Khajah MA, Babyson RS, Renno WM, Ezeamuzie CI, Benter IF, et al. Ang-(1–7)/MAS1 receptor axis inhibits allergic airway inflammation via blockade of Src-mediated EGFR transactivation in a murine model of asthma. PLoS ONE. 2019;2019:1. ; Barroso LC, Magalhaes GS, Galvão I, Reis AC, Souza DG, Sousa LP, et al. Angiotensin-(1–7) promotes resolution of neutrophilic inflammation in a model of antigen-induced arthritis in mice. Front Immunol. 2017;2017:1. ; Gregorio JF, Magalhães GS, Rodrigues-Machado MG, Gonzaga KER, Motta-Santos D, Cassini-Vieira P, Barcelos LS, Vieira MAR, Santos RAS, Campagnole-Santos MJ. Angiotensin-(1-7)/mas receptor modulates anti-inflammatory effects of exercise training in a model of chronic allergic lung inflammation. Life Sci. 2021;1(282):119792–802. (PMID: 10.1016/j.lfs.2021.119792) ; Zaidan I, Tavares LP, Sugimoto MA, Lima KM, Negreiros-Lima GL, Teixeira LCR, et al. Angiotensin-(1–7)/MasR axis promotes migration of monocytes/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis. JCI Insight. 2022;2022:1. ; Vago JP, Tavares LP, Garcia CC, Lima KM, Perucci LO, Vieira ÉL, et al. The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution. J Immunol. 2015;2015:1. ; Do Camargo LN, Righetti RF, De Almeida FM, Dos Santos TM, Fukuzaki S, Martins NAB, et al. Modulating asthma-COPD overlap responses with IL-17 inhibition. Front Immunol. 2023;2023:1. ; Felix FB, Vago JP, de Fernandes DO, Martins DG, Moreira IZ, Gonçalves WA, et al. Biochanin a regulates key steps of inflammation resolution in a model of antigen-induced arthritis via GPR30/PKA-dependent mechanism. Front Pharmacol. 2021;12:1. (PMID: 10.3389/fphar.2021.662308) ; Harju TH. Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax. 2006;61(7):579–84. (PMID: 16517571210465010.1136/thx.2005.056291) ; Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, et al. The ACE2/angiotensin-(1–7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1–7). Physiol Rev. 2018;98(1):505–53. (PMID: 2935151410.1152/physrev.00023.2016) ; Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ, et al. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol. 2007;119(5):1258–66. (PMID: 1741240210.1016/j.jaci.2007.02.023) ; Raeiszadeh Jahromi S, Mahesh PA, Jayaraj BS, Madhunapantula SRV, Holla AD, Vishweswaraiah S, et al. Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case–control study. J Asthma. 2014;51(10):1004–13. (PMID: 2496044010.3109/02770903.2014.938353) ; Kearley J, Barker JE, Robinson DS, Lloyd CM. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med. 2005;202(11):1539–47. (PMID: 16314435135074310.1084/jem.20051166) ; Zhang M, Qian YY, Chai SJ, Liang ZY, Xu Q, Wu ZQ, et al. Enhanced local Foxp3 expression in lung tissue attenuates airway inflammation in a mouse model of asthma. J Asthma. 2014;51(5):451–8. (PMID: 2446772210.3109/02770903.2014.887727) ; Lu Y, Guo Y, Xu L, Li Y, Cao L. Foxp3 regulates ratio of Treg and NKT cells in a mouse model of asthma. Mol Cell Biochem. 2015;403(1–2):25–31. (PMID: 2563680410.1007/s11010-015-2333-2) ; Huynh MLN, Malcolm KC, Kotaru C, Tilstra JA, Westcott JY, Fadok VA, et al. Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am J Respir Crit Care Med. 2005;172(8):972–9. (PMID: 1604078610.1164/rccm.200501-035OC) ; Proto JD, Doran AC, Gusarova G, Yurdagul A, Sozen E, Subramanian M, et al. Regulatory T cells promote macrophage efferocytosis during inflammation resolution. Immunity. 2018;2018:1. ; Bjerregaard A, Laing IA, Backer V, Sverrild A, Khoo SK, Chidlow G, et al. High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: a prospective cohort study. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2017;2017:1. ; Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest. 2006;129(6):1492–9. (PMID: 1677826610.1378/chest.129.6.1492) ; Tibbitt CA, Stark JM, Martens L, Ma J, Mold JE, Deswarte K, et al. Single-cell RNA sequencing of the T helper cell response to house dust mites defines a distinct gene expression signature in airway Th2 cells. Immunity. 2019;2019:1. ; Hadjigol S, Netto KG, Maltby S, Tay HL, Nguyen TH, Hansbro NG, et al. Lipopolysaccharide induces steroid-resistant exacerbations in a mouse model of allergic airway disease collectively through IL-13 and pulmonary macrophage activation. Clin Exp Allergy. 2019;50(1):82–94. (PMID: 3157997310.1111/cea.13505) ; Baraldo S, Contoli M, Bazzan E, Turato G, Padovani A, Marku B, et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol. 2012;130(6):1307–14. (PMID: 2298179110.1016/j.jaci.2012.08.005) ; Wark PAB, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;2005:1. ; Georas SN, Rezaee F. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol. 2014;2014:1. ; Melo EM, Del Sarto J, Vago JP, Tavares LP, Rago F, Gonçalves APF, et al. Relevance of angiotensin-(1–7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection. Pharmacol Res. 2021;2021:1. ; de Carvalho Santuchi M, Dutra MF, Vago JP, Lima KM, Galvão I, de Souza-Neto FP, et al. Angiotensin-(1–7) and alamandine promote anti-inflammatory response in macrophages in vitro and in vivo. Med Inflam. 2019;2019:1. (PMID: 10.1155/2019/2401081) ; Souza LL, Costa-Neto CM. Angiotensin-(1–7) decreases LPS-induced inflammatory response in macrophages. J Cell Physiol. 2012;2012:1. ; D’Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, Britos MF, et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest. 2009;2009:1.
- Contributed Indexing: Keywords: Ang-(1–7); Chronic inflammation; Eosinophil; Inflammation; Resolution of inflammation
- Substance Nomenclature: 0 (angiotensin I (1-7))
- Entry Date(s): Date Created: 20240424 Date Completed: 20240520 Latest Revision: 20240528
- Update Code: 20240528
|
